Elanco Animal Health IncorporatedELANNYSE
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank37
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P37
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-3.70%
Q3 2025-12.25%
Q2 202517.30%
Q1 202513.67%
Q4 2024-7.12%
Q3 2024-8.76%
Q2 20245.04%
Q1 202415.41%
Q4 2023-6.71%
Q3 2023-11.33%
Q2 20237.95%
Q1 20237.92%
Q4 20221.68%
Q3 2022-13.12%
Q2 20226.19%
Q1 2022-1.22%
Q4 2021-4.39%
Q3 2021-11.17%
Q2 202110.63%
Q1 2021-6.98%
Q4 202034.71%
Q3 202070.58%
Q2 2020-10.55%
Q1 2020-2.10%
Q4 2019-3.33%
Q3 2019-4.28%
Q2 201910.93%
Q1 2019-2.16%
Q4 20183.41%
Q3 2018-6.33%
Q2 20186.17%
Q1 2018-8.54%
Q4 20171.08%
Q3 20170.26%
Q2 20170.00%
Q1 20170.00%